Aberdeen Group’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
Other funds holding ABMD
TRSOTSOK
BTI
IA
AW
HNB
Aberdeen Group's ABMD Position: Q4 2022 in Review
Aberdeen Group sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 30,611 shares — an estimated $7.52M sold.
Aberdeen Group first reported a position in ABMD in Q4 2017 and held it in 20 quarters. The position peaked at $55.9M in Q3 2018. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.
- Aberdeen Group reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
- Aberdeen Group sold 30,611 Abiomed Inc shares in Q4 2022, an estimated $7.52M.
- Aberdeen Group first reported a position in Abiomed Inc in Q4 2017 and held it in 20 quarters.
- Aberdeen Group's Abiomed Inc position peaked at $55.9M in Q3 2018.
- 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.
Based on Aberdeen Group's 13F filing for Q4 2022, filed 10 Feb 2023.